Placo announced that the company signed a “Property Rights Transaction Contract” with CITIC Agriculture on December 10, 2025, and obtained a “Property Transaction Certificate” issued by Shanghai Joint Property Exchange Co., Ltd. on December 15, 2025, and transferred 4.04% of Zhongpu Biopharmaceutical Co., Ltd.'s shares for 175.14,300 yuan. After the transaction is completed, Placo will hold 51.01% of Zhongpu Biotech's shares, and Zhongpu Biotech will become a subsidiary of Placo Holdings. The source of transaction capital is the company's own capital, which does not affect the normal development of the existing main business, and will not have a significant impact on the company's financial situation and operating results.

Placo announced that the company signed a “Property Rights Transaction Contract” with CITIC Agriculture on December 10, 2025, and obtained a “Property Transaction Certificate” issued by Shanghai Joint Property Exchange Co., Ltd. on December 15, 2025, and transferred 4.04% of Zhongpu Biopharmaceutical Co., Ltd.'s shares for 175.14,300 yuan. After the transaction is completed, Placo will hold 51.01% of Zhongpu Biotech's shares, and Zhongpu Biotech will become a subsidiary of Placo Holdings. The source of transaction capital is the company's own capital, which does not affect the normal development of the existing main business, and will not have a significant impact on the company's financial situation and operating results.